CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
15 hedge funds and large institutions have $8.44M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$270K | |
| 2 | -$242K | |
| 3 | -$38.3K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$15.1K |
| 5 |
Morgan Stanley
New York
|
-$10.3K |